Skip to main content
Login
Contact
Subscribe
Search form
Search
The Decatur Daily Democrat
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Photos
Videos
Games
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Arena Pharmaceuticals
(NQ:
ARNA
)
80.35
USD
+0.86 (+1.08%)
Official Closing Price
Updated: 4:22 PM EST, Feb 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Arena Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stocks With Rising Relative Strength: Arena Pharmaceuticals
February 26, 2021
Arena Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
From
Investor's Business Daily
Arena Pharmaceuticals Inc (ARNA) Q4 2020 Earnings Call Transcript
February 24, 2021
ARNA earnings call for the period ending December 31, 2020.
Tags
Market News
ARNA
From
Motley Fool
Recap: Arena Pharmaceuticals Q4 Earnings
February 23, 2021
Shares of Arena Pharmaceuticals (NASDAQ:ARNA) were flat in after-market trading after the company reported Q4 results. Quarterly ...
Tags
Earnings
ARNA
Benzinga
From
Benzinga
Arena Reports Fourth Quarter Financial Results with Strong Liquidity Position and Maintained Pipeline Progress Over the Quarter
February 23, 2021
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2020.
From
Business Wire News Releases
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
February 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ESPR
CELC
MGNX
From
Benzinga
Earnings Scheduled For February 23, 2021
February 23, 2021
Companies Reporting Before The Bell • MFA Finl (NYSE:MFA) is likely to report quarterly earnings at $0.07 per share on ...
Tags
CDEV
NXST
MASI
From
Benzinga
Arena Pharmaceuticals Earnings Preview
February 22, 2021
On Tuesday, February 23, Arena Pharmaceuticals (NASDAQ:ARNA) will release its latest earnings report. Check out Benzinga's preview ...
Tags
Market News
Earnings
ARNA
From
Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ...
Tags
ALIM
ICPT
EDIT
From
Benzinga
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 18, 2021
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on February 15, 2021, the Compensation Committee of its Board of Directors granted to eleven new employees inducement stock options to...
From
Business Wire News Releases
Arena Pharmaceuticals to Release Fourth Quarter & Full-Year 2020 Financial Results and Provide Corporate Update on February 23
February 16, 2021
Arena Pharmaceuticals to Release Fourth Quarter & Full-Year 2020 Financial Results and Provide Corporate Update on February 23.
From
Business Wire News Releases
Arena Pharmaceuticals Announces Changes to Board of Directors
February 16, 2021
Industry veteran Garry Neil, MD named Board Chair. Nawal Ouzren, CEO of Sensorion named to Board.
From
Business Wire News Releases
Code red — here’s what it means for the stock market now that company insiders are selling shares
February 04, 2021
The stock market is vulnerable to a decline because of overvaluation, while "reopening" and cyclical stocks have been overplayed.
Tags
MRVL
ROAD
CRSP
From
MarketWatch
Arena Pharmaceuticals Completes Full Enrollment of Etrasimod Phase 3 ELEVATE UC 52 Trial
February 02, 2021
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that it has completed full enrollment of the Phase 3 ELEVATE UC 52 trial evaluating the safety and efficacy of etrasimod, a highly selective,...
From
Business Wire News Releases
Cannabis Stock Gainers And Losers From January 29, 2021
January 29, 2021
GAINERS: Rhinomed(OTCQB: RHNMF) shares closed up 37.49% at $0.12 Cannabix Technologies(PINK: BLOZF) shares closed up ...
Tags
CANN
NEXCF
CXXIF
From
Benzinga
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 22, 2021
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on January 15, 2021, the Compensation Committee of its Board of Directors granted to five new employees inducement stock options to...
From
Business Wire News Releases
Arena Pharmaceuticals Larger Than S&P 500 Component HollyFrontier
January 05, 2021
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Arena Pharmaceuticals Inc (ARNA) was identified as having a larger market cap than the smaller end of the...
Tags
Stocks
From
Market News Video
Arena Pharmaceuticals Earns IBD Rating Upgrade
December 28, 2020
Arena Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
From
Investor's Business Daily
Arena Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 13
December 22, 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, is scheduled to present virtually at the 39th Annual J.P. Morgan...
From
PR Newswire
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 18, 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on December 15, 2020, the Compensation Committee of its Board of Directors granted to five new employees inducement stock options to...
From
PR Newswire
First Week of March 2021 Options Trading For Arena Pharmaceuticals (ARNA)
December 18, 2020
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options become available this week, for the March 2021 expiration. One of the key data points that goes into the price an option buyer is willing...
Tags
Stocks
From
Market News Video
The Week Ahead In Biotech: 2 IPOs Plus FDA Decisions On Moderna's COVID Vaccine And Drugs From Amgen, MacroGenics
December 13, 2020
Biotech stocks advanced for a third straight week, defying the broader market weakness. The space got solid support from positive stock ...
Tags
PFE
RHHBY
Benzinga
From
Benzinga
Arena Pharmaceuticals to Present Data from the Phase 2b ADVISE Trial - Late-Breaker at Revolutionizing Atopic Dermatitis Conference
December 11, 2020
- Data selected for late-breaker oral presentation on December 14
From
PR Newswire
Arena Pharmaceuticals Gets Relative Strength Rating Upgrade
December 09, 2020
Arena Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
From
Investor's Business Daily
Arena Pharmaceuticals Achieves Target Enrollment for Etrasimod Phase 3 ELEVATE UC 52 Trial
December 08, 2020
- Evaluating 2 mg etrasimod in study participants with moderately to severely active ulcerative colitis (UC)
From
PR Newswire
Arena Pharmaceuticals Announces R&D Leadership Transition
November 30, 2020
Arena Pharmaceuticals announces the appointment of Paul D. Streck, M.D., as Senior Vice President, Clinical Development and Chief Medical Officer.
From
Business Wire News Releases
Cannabis Central: The Pure-Play Pot Stock Index Moved Up On Monday
November 24, 2020
The Pure-Play Pot Stock Index went up 1.1% on Monday.14 of the 25 constituents went up, 9 went down and 2 had no change in price. In addition, 2 of the 3 index categories went up as well.
Tags
Healthcare
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Arena Pharmaceuticals to Present at the Evercore ISI HealthCONx Conference on December 1
November 24, 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the 3rd...
From
PR Newswire
First Week of July 2021 Options Trading For Arena Pharmaceuticals (ARNA)
November 23, 2020
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options begin trading this week, for the July 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is...
Tags
Stocks
From
Market News Video
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 19, 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on November 15, 2020, the Compensation Committee of its Board of Directors granted to 13 new employees inducement stock options to...
From
PR Newswire
Benzinga's Top Upgrades, Downgrades For November 19, 2020
November 19, 2020
Upgrades According to MKM Partners, the prior rating for Target Corp (NYSE: TGT) was changed from Sell to Neutral. Target earned ...
Tags
JPM
FCEL
C
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.